Canaccord analyst William Plovanic raised the firm’s price target on iRhythm (IRTC) to $170 from $139 and keeps a Buy rating on the shares. The firm said they delivered a rock-solid beat and raise in the core business with its early detection strategy coming into form and the company raising its FY25 revenue and adjusted EBITDA due to strong Zio Monitor performance.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IRTC:
- iRhythm price target raised to $190 from $145 at JPMorgan
- Irhythm Technologies: Strong Performance and Growth Potential Drive Buy Rating
- Irhythm Technologies: Strong Performance and Promising Outlook Drive Buy Rating
- iRhythm Technologies Reports Strong Q2 2025 Growth
- Closing Bell Movers: Apple up 2%, Amazon down over 6% after results